GENDER-AFFIRMING HORMONE THERAPY MAY NOT INCREASE CVD RISK FOR TRANSGENDER ADOLESCENTS

Source :: States News Service. May 20, 2021
Publication Year :: 2021
Abstract: DALLAS, TX -- The following information was released by the American Heart Association (AHA): American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Conference -- Presentation MP65 Research Highlights: Before [...]

Subjects :: Hormone therapy -- Research
Transgender people -- Research
Teenagers -- Research
Youth -- Research
Cardiovascular diseases -- Risk factors -- Prevention -- Research
Epidemiology -- Research
News, opinion and commentary

Tools